Area Dose–Response and Radiation Origin of Childhood Thyroid Cancer in Fukushima Based on Thyroid Dose in UNSCEAR 2020/2021: High 131I Exposure Comparable to Chernobyl

Author:

Kato Toshiko1ORCID,Yamada Kosaku2ORCID,Hongyo Tadashi3

Affiliation:

1. Independent Researcher, Nara 630-8242, Japan

2. Independent Researcher, Kyoto 611-0001, Japan

3. Department of Radiation Biology, Health Sciences, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan

Abstract

The FMU and the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) concluded that the high incidence of thyroid cancer after the Fukushima nuclear accident was not the result of radiation exposure, but rather might have been overdiagnosis based on the low thyroid dose estimated in the UNSCEAR 2020/2021 report. In this study, the origin of increased PTC in Fukushima was examined based on the thyroid dose estimated by UNSCEAR. The dose–response relationship of the incidence rate per person-years (PY) was analyzed for four areas in Fukushima prefecture via regression analysis. The linear response of the annual incidence rates to thyroid dose in the first six years showed that the dominant origin of childhood thyroid cancer was radiation exposure. Excess absolute risk (EAR) proportionally increased with thyroid dose, with an EAR/104 PY Gy of 143 (95%CI: 122, 165) in the second TUE (p < 0.001), which is approximately 50–100 times higher than the EAR/104 PY Gy ≒ 2.3 observed after the Chernobyl accident. This suggests an underestimation of the thyroid dose by UNSCEAR of approximately 1/50~1/100 compared with the thyroid dose for Chernobyl. The increased childhood thyroid cancer in Fukushima was found to arise from radioactive iodine exposure, which was comparable to that in Chernobyl.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference54 articles.

1. Radiation Medical Science Center for the Fukushima Health Management Survey (2023, August 01). Materials and Minutes of Prefectural Oversight Committee Meetings. Available online: https://fhms.jp/en/fhms/outline/materials/.

2. Radiation Medical Science Center for the Fukushima Health Management Survey (2023, August 01). Report of the Fukushima Health Management Survey 2019. Available online: https://fukushima-mimamori.jp/outline/uploads/report_r1.pdf.

3. Fukushima Prefectural Oversight Committee Meeting for FHMS (2023, August 01). Interim Summary of the results of FHMS. (In Japanese).

4. Tsugane, S. (2023, August 01). Estimation of the number of prevalent thyroid cancer patients in Fukushima Prefecture, Thyroid Examination Evaluation Subcommittee. (In Japanese).

5. Fukushima Prefectural Oversight Committee Meeting for FHMS (2023, August 01). Summary of the Results of Full-Scale Screening (Second Examination). (In Japanese).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3